KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Non-Controlling Interests (2023 - 2025)

Edwards Lifesciences has reported Income from Non-Controlling Interests over the past 3 years, most recently at -$800000.0 for Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests rose 42.86% year-over-year to -$800000.0; the TTM value through Dec 2025 reached -$4.1 million, up 16.33%, while the annual FY2025 figure was -$4.1 million, 16.33% up from the prior year.
  • Income from Non-Controlling Interests for Q3 2025 was -$800000.0 at Edwards Lifesciences, up from -$1.7 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at -$200000.0 in Q4 2023 and troughed at -$1.7 million in Q2 2025.
  • A 3-year average of -$1.2 million and a median of -$1.3 million in 2024 define the central range for Income from Non-Controlling Interests.
  • Biggest five-year swings in Income from Non-Controlling Interests: plummeted 550.0% in 2024 and later skyrocketed 42.86% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$200000.0 in 2023, then plummeted by 550.0% to -$1.3 million in 2024, then surged by 38.46% to -$800000.0 in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for EW at -$800000.0 in Q3 2025, -$1.7 million in Q2 2025, and -$1.6 million in Q1 2025.